Futura Medical plc – LSE:FUM.L

Futura Medical stock price today

GBP 39.3
+7.51
+23.66%
Financial Health
0
1
2
3
4
5
6
7
8
9

Futura Medical stock price monthly change

-13.41%
month

Futura Medical stock price quarterly change

-13.41%
quarter

Futura Medical stock price yearly change

+25.17%
year

Futura Medical key metrics

Market Cap
96.11M
Enterprise value
N/A
P/E
-21.27
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
3653.75
Price/Book
11.80
PEG ratio
0.25
EPS
-0.04
Revenue
N/A
EBITDA
-18.49M
Income
-12.35M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-34235.89%
Oper. margin
-42752.63%
Gross margin
0%
EBIT margin
-42752.63%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Futura Medical stock price history

Futura Medical stock forecast

Futura Medical financial statements

Futura Medical plc (LSE:FUM.L): Profit margin
Jun 2022 0 -2.49M
Dec 2022 0 -3.34M
Jun 2023 1.70M -1.75M -103.27%
Dec 2023 1.39M -4.75M -339.95%
Futura Medical plc (LSE:FUM.L): Analyst Estimates
2027 38.59M 18.61M 48.24%
  • Analysts Price target

  • Financials & Ratios estimates

Futura Medical plc (LSE:FUM.L): Debt to assets
Jun 2022 8766083 1.38M 15.84%
Dec 2022 6472662 1.75M 27.08%
Jun 2023 10207540 2.19M 21.51%
Dec 2023 11816353 6.33M 53.65%
Futura Medical plc (LSE:FUM.L): Cash Flow
Dec 2021 -1.99M -418.34K 24.80K
Jun 2022 -3.41M -301.62K 21.83K
Dec 2022 -2.35M -439.07K 147.75K
Jun 2023 -587.11K -6.88K 4.40M

Futura Medical alternative data

Futura Medical plc (LSE:FUM.L): Employee count
Aug 2023 12
Sep 2023 12
Oct 2023 12
Nov 2023 12
Dec 2023 12
Jan 2024 12
Feb 2024 12
Mar 2024 12
Apr 2024 12
May 2024 12
Jun 2024 12
Jul 2024 12

Futura Medical other data

Insider Compensation
Mr. James Henry Barder (1960) Chief Executive Officer & Executive Director
$309,310
Mr. Kenneth William James (1953) Head of R&D & Executive Director
$248,220
  • What's the price of Futura Medical stock today?

    One share of Futura Medical stock can currently be purchased for approximately $39.3.

  • When is Futura Medical's next earnings date?

    Unfortunately, Futura Medical's (FUM.L) next earnings date is currently unknown.

  • Does Futura Medical pay dividends?

    No, Futura Medical does not pay dividends.

  • How much money does Futura Medical make?

    Futura Medical has a market capitalization of 96.11M.

  • What is Futura Medical's stock symbol?

    Futura Medical plc is traded on the LSE under the ticker symbol "FUM.L".

  • What is Futura Medical's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Futura Medical?

    Shares of Futura Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Futura Medical's key executives?

    Futura Medical's management team includes the following people:

    • Mr. James Henry Barder Chief Executive Officer & Executive Director(age: 65, pay: $309,310)
    • Mr. Kenneth William James Head of R&D & Executive Director(age: 72, pay: $248,220)
  • How many employees does Futura Medical have?

    As Jul 2024, Futura Medical employs 12 workers.

  • When Futura Medical went public?

    Futura Medical plc is publicly traded company for more then 22 years since IPO on 22 Jul 2003.

  • What is Futura Medical's official website?

    The official website for Futura Medical is futuramedical.com.

  • How can i contact Futura Medical?

    Futura Medical can be reached via phone at +44 1483 685670.

Futura Medical company profile:

Futura Medical plc

futuramedical.com
Exchange:

LSE

Full time employees:

12

Industry:

Biotechnology

Sector:

Healthcare

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Surrey Technology Centre
Guildford, GU2 7YG

:
ISIN: GB0033278473
CUSIP: G3698F100